Trade Summary

4 days ago, Amoroso Michael, serving as Pres, CEO at Precision Biosciences Inc (DTIL), sold 20,559 shares at $3.84 per share, for a total transaction value of $78,947.00. Following this transaction, Amoroso Michael now holds 243,392 shares of DTIL.

This sale represents a 8.00% decrease in Amoroso Michael's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, February 18, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 19, 2026, 1 day after the trade was made.

Precision Biosciences Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.